GLP-1 Meds Can reduce Heart Attacks by 20% or more... [CNN]

Hey everyone — this CNN piece covers research I consider some of the most important news in our field, so here's the summary.

Heart disease is still the leading cause of death worldwide. And the research now shows that medications like Semaglutide and Tirzepatide don't just help with weight — they significantly reduce the risk of heart attacks and other major cardiovascular events. We're talking 20% or greater reductions in major events, in large trials.

Here's the part I find most remarkable: the heart protection shows up even independent of weight loss. Read that again. Even before the pounds come off, patients on these medications show reduced cardiac risk. The leading explanation ties back to what we keep seeing across the research — these drugs calm chronic inflammation and improve metabolic health directly, and your cardiovascular system benefits immediately.

For context: a 20% reduction in major cardiac events is the kind of number that gets medications prescribed purely as heart drugs. Statins built an entire era of preventive medicine on numbers in that neighborhood.

So when someone tells me these are "vanity drugs," I point them here. Our patients come in to lose weight — and yes, the transformations are real — but the blood pressure improvements, the metabolic markers moving the right direction, the reduced cardiac risk... that's the stuff that adds years to lives, not just pounds off scales.

If heart disease runs in your family, this research should be part of your decision. Come talk to us.

-Daryl

Book a FREE consult now <- Click There!

www.pnwmedicalgroup.com

Puyallup: 253-340-2270

Federal Way: 253-363-8877